BURLINGAME, Calif., March 16, 2022 /PRNewswire/ -- Vector Laboratories, the pioneer of innovative proteomic and glycomic solutions, today opened its new facility in Newark, California, where it will ...

BURLINGAME, Calif., Sept. 7, 2021 /PRNewswire/ -- Vector Laboratories, the market leader in the development and manufacture of labeling and detection reagents for biomedical research, today announced ...

NEWARK, Calif.--(BUSINESS WIRE)--Vector Laboratories, the pioneer of innovative proteomic and glycomic solutions, today announced the launch of its novel product Glysite™ Scout Glycan Screening Kits.

NEWARK, Calif.--(BUSINESS WIRE)--Vector Laboratories, a manufacturing partner of reagents and critical components for the development and production of life sciences tools, diagnostics, and ...

BURLINGAME, CA — October 18, 2017 — Vector Laboratories, a leader in the development and manufacture of labeling and detection reagents for biomedical research, announced today (Oct. 18) the ...

Vector Laboratories, a manufacturing partner of reagents and critical components for the development and production of life sciences tools, diagnostics, and clinical-stage biotherapeutics, announced ...

The new kit combines Vector's validated lectins with Navinci's in situ PLA technology to gain insights beyond protein expression The Glysite™ Explorer in situ PLA Glycan Detection Kit is a fully ...

NEWARK, Calif. — Vector Laboratories, a manufacturing partner of reagents and critical components for the development and production of life sciences tools, diagnostics, and clinical-stage ...

GTCR, a leading private equity firm, today announced that it has completed a strategic equity investment in Vector Laboratories, Inc. (“Vector” or the “Company”), through GTCR’s previously established ...

News and research before you hear about it on CNBC and others. Claim your 1-week free trial to StreetInsider Premium here. BURLINGAME, Calif., Sept. 7, 2021 /PRNewswire/ -- Vector Laboratories, the ...